home / stock / knbif / knbif short
Short Information | Kane Biotech (OTCMKTS:KNBIF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 319,226 |
Total Actual Volume | 499,826 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 15 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 15,961 |
Average Short Percentage | 75.63% |
Is there a KNBIF Short Squeeze or Breakout about to happen?
See the KNBIF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-12-2024 | $0.1036 | $0.1036 | $0.1036 | $0.1036 | 1,000 | 1,000 | 100% |
07-11-2024 | $0.110046 | $0.109 | $0.110046 | $0.109 | 3,000 | 1,000 | 33.33% |
07-08-2024 | $0.121 | $0.1123 | $0.121 | $0.1123 | 1,600 | 1,000 | 62.5% |
07-05-2024 | $0 | $0.111 | $0 | $0 | 15 | 15 | 100% |
06-27-2024 | $0.111 | $0.111 | $0.111 | $0.111 | 7,000 | 7,000 | 100% |
06-26-2024 | $0.10516 | $0.105852 | $0.1062 | $0.1 | 89,000 | 38,000 | 42.7% |
05-23-2024 | $0.115 | $0.110969 | $0.115 | $0.110969 | 7,500 | 2,500 | 33.33% |
05-15-2024 | $0 | $0.0939 | $0 | $0 | 5 | 5 | 100% |
04-12-2024 | $0.094 | $0.0898 | $0.094 | $0.0898 | 84,000 | 34,000 | 40.48% |
04-04-2024 | $0.09 | $0.09 | $0.09 | $0.09 | 50,000 | 5,000 | 10% |
03-26-2024 | $0.0788 | $0.0786 | $0.0788 | $0.0786 | 2,000 | 1,000 | 50% |
02-15-2024 | $0.0661 | $0.0725 | $0.0725 | $0.0617 | 108,000 | 100,000 | 92.59% |
02-02-2024 | $0.0662 | $0.0662 | $0.0662 | $0.0662 | 48,001 | 48,001 | 100% |
12-20-2023 | $0.0563 | $0.06 | $0.06 | $0.055377 | 59,000 | 45,000 | 76.27% |
10-26-2023 | $0.0507 | $0.0507 | $0.0507 | $0.0507 | 205 | 205 | 100% |
10-17-2023 | $0.051 | $0.051 | $0.051 | $0.051 | 8,000 | 8,000 | 100% |
10-13-2023 | $0.05 | $0.05 | $0.05 | $0.05 | 200 | 200 | 100% |
10-10-2023 | $0.045 | $0.042 | $0.045 | $0.042 | 14,000 | 10,000 | 71.43% |
10-05-2023 | $0.048 | $0.048 | $0.048 | $0.048 | 14,300 | 14,300 | 100% |
09-21-2023 | $0.0562 | $0.0562 | $0.0562 | $0.0562 | 3,000 | 3,000 | 100% |
News, Short Squeeze, Breakout and More Instantly...
WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has received ISO 13485:2016 Medical Device Single Audit Program (“MDSAP”) Quality Certification as a designer, de...
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with Arizona-based Omni Bioceutical Innovations Inc. (“Omni”) for its c...
WINNIPEG, Manitoba, June 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”...